Three pharmaceutical groups have sued North Dakota in federal court over a new law that aims to stop pharmaceutical companies from limiting hospitals’ access to discount drugs through the 340B Drug Pricing Program.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
